3 ms·

Except in countries with socialised healthcare.

• Scoundreller 7y ago
  Even they will develop criteria for when they pay for an intervention or not. Unfortunately, low-value but worthwhile endeavours often go unfunded or underpromoted because the infrastructure makes it too expensive. Metformin is cheap and large tracts of the population may benefit from taking it proactively, but once you factor in the cost of MD visits for otherwise healthy people, the public benefit can swing into the negatives.